Page last updated: 2024-08-01 20:30:25

chlorin p6

Description

chlorin p6: structure given in first source; a new photosensitizer for treatment of glioma tumors [MeSH]

Cross-References

ID SourceID
PubMed CID5489033
SCHEMBL ID13806510
MeSH IDM0197276

Synonyms (7)

Synonym
chlorin p6
(17s,18s)-18-(2-carboxyethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18,22,23-tetrahydroporphyrin-2,20-dicarboxylic acid
21h,23h-porphine-2,20-dicarboxylic acid, 18-(2-carboxyethyl)-12-ethenyl-7-ethyl-17,18-dihydro-3,8,13,17-tetramethyl-, (17s-trans)-
22006-68-4
(5z,10z,14z,17s,18s,19e)-18-(2-carboxyethyl)-7-ethyl-3,8,13,17-tetramethyl-12-vinyl-17,18,21,23-tetrahydroporphyrin-2,20-dicarboxylic acid
(17s,18s)-18-(2-carboxyethyl)-20-(carboxymethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-2-carboxylic acid
SCHEMBL13806510

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (9.38)18.2507
2000's16 (50.00)29.6817
2010's13 (40.63)24.3611
2020's0 (0.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other36 (100.00%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
formic acidmonocarboxylic acidantibacterial agent;
astringent;
metabolite;
protic solvent;
solvent
2006200618.0low000100
histaminearalkylamino compound;
imidazoles
human metabolite;
mouse metabolite;
neurotransmitter
2011201312.0low000020
cetyltrimethylammonium ionquaternary ammonium ion2002200222.0low000100
lysineaspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid
algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
1992199232.0low001000
adenosine diphosphateadenosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate
fundamental metabolite;
human metabolite
2005200519.0low000100
mannitolmannitolallergen;
antiglaucoma drug;
compatible osmolytes;
Escherichia coli metabolite;
food anticaking agent;
food bulking agent;
food humectant;
food stabiliser;
food thickening agent;
hapten;
metabolite;
osmotic diuretic;
sweetening agent
2006200618.0low000100
tryptophanerythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
tryptophan zwitterion;
tryptophan
antidepressant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
2007201713.3low000210
trichloroacetic acidmonocarboxylic acid;
organochlorine compound
carcinogenic agent;
metabolite;
mouse metabolite
2006200618.0low000100
n-vinyl-2-pyrrolidinonepyrrolidin-2-ones2005200519.0low000100
4-nitrosodimethylanilinedimethylaniline;
nitroso compound;
tertiary amino compound
2008200816.0low000100
neutral redhydrochlorideacid-base indicator;
dye;
two-colour indicator
2004200420.0low000100
deuterium oxidedeuterated compound;
water
NMR solvent2006200618.0low000100
sodium azideinorganic sodium saltantibacterial agent;
explosive;
mitochondrial respiratory-chain inhibitor;
mutagen
2006200618.0low000100
chlorin2006201115.5low000110
prolineamino acid zwitterion;
glutamine family amino acid;
L-alpha-amino acid;
proline;
proteinogenic amino acid
algal metabolite;
compatible osmolytes;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
201520159.0low000010
singlet oxygenchalcogen;
monoatomic oxygen;
nonmetal atom
macronutrient2008200816.0low000100
carbodiimidescarbodiimide2011201113.0low000010
purpurin 182006200717.5medium000200
riboflavinflavin;
vitamin B2
anti-inflammatory agent;
antioxidant;
cofactor;
Escherichia coli metabolite;
food colouring;
fundamental metabolite;
human urinary metabolite;
mouse metabolite;
photosensitizing agent;
plant metabolite
2006200618.0low000100
dansylproline201520159.0medium000010
curcuminaromatic ether;
beta-diketone;
diarylheptanoid;
enone;
polyphenol
anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
biological pigment;
contraceptive drug;
dye;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
flavouring agent;
food colouring;
geroprotector;
hepatoprotective agent;
immunomodulator;
iron chelator;
ligand;
lipoxygenase inhibitor;
metabolite;
neuroprotective agent;
nutraceutical;
radical scavenger
201720177.0low000010
ranitidineC-nitro compound;
furans;
organic sulfide;
tertiary amino compound
anti-ulcer drug;
drug allergen;
environmental contaminant;
H2-receptor antagonist;
xenobiotic
2011201113.0low000010
1-palmitoyl-2-oleoylglycero-3-phosphoglycerolphosphatidylglycerol201720177.0low000010
phytochlorin2008201413.0low000120
celluloseglycoside2012201212.0low000010
phosphatidylcholines1,2-diacyl-sn-glycero-3-phosphocholine2012201212.0low000010
chlorophyll achlorophyll;
methyl ester
cofactor1998199826.0low001000
chlorin e42008200816.0medium000100
warfarinbenzenes;
hydroxycoumarin;
methyl ketone
2007200717.0low000100
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Adenocarcinoma02004200519.5low000200
Adenocarcinoma, Basal Cell02004200519.5low000200
Benign Neoplasms02012201212.0low000010
Breast Cancer02004200420.0low000100
Breast Neoplasms02004200420.0low000100
Cancer of Colon02004200519.5low000200
Cancer of Liver02008200816.0low000100
Cancer of Mouth02006201712.4low000140
Cancer of Nasopharynx02005200519.0low000100
Cancer of Skin01992199232.0low001000
Cancer of the Tongue02014201410.0low000010
Carcinoma, Epidermoid02006201413.0low000130
Carcinoma, Hepatocellular02008200816.0low000100
Carcinoma, Squamous Cell02006201413.0low000130
Colonic Neoplasms02004200519.5low000200
Dermatitis, Contact, Phototoxic02004200420.0low000100
Disease Models, Animal02013201311.0low000010
Experimental Mammary Neoplasms01995199529.0low001000
Experimental Neoplasms02010201611.0low000110
Experimental Radiation Injuries01998199826.0low001000
Glial Cell Tumors01992199232.0low001000
Glioma01992199232.0low001000
Hepatocellular Carcinoma02008200816.0low000100
Leukemia L 121001995199529.0low001000
Liver Neoplasms02008200816.0low000100
Mouth Neoplasms02006201712.4low000140
Nasopharyngeal Neoplasms02005200519.0low000100
Necrosis01992201122.5low001010
Neoplasms02012201212.0low000010
Skin Neoplasms01992199232.0low001000
Tongue Neoplasms02014201410.0low000010

Safety/Toxicity (1)

ArticleYear
Conjugation of chlorin p(6) to histamine enhances its cellular uptake and phototoxicity in oral cancer cells.
Cancer chemotherapy and pharmacology, , Volume: 68, Issue:2
2011